Literature DB >> 1353966

Multidrug resistance in human cancer.

L J Goldstein1, I Pastan, M M Gottesman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1353966     DOI: 10.1016/1040-8428(92)90057-w

Source DB:  PubMed          Journal:  Crit Rev Oncol Hematol        ISSN: 1040-8428            Impact factor:   6.312


× No keyword cloud information.
  21 in total

Review 1.  Pharmacological issues relating to viral resistance.

Authors:  D J Back
Journal:  Infection       Date:  1999       Impact factor: 3.553

Review 2.  The mucosa of the small intestine: how clinically relevant as an organ of drug metabolism?

Authors:  Margaret M Doherty; William N Charman
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

3.  The use of Tris-lipidation to modify drug cytotoxicity in multidrug resistant cells expressing P-glycoprotein or MRP1.

Authors:  Ross A Davey; Mary W Davey; Karen V Cullen; Xanthe E Wells; Craig L Francis; Hua-Ming Williams; Qi Yang; Minoo J Moghaddam; Fred Widmer; Robert G Whittaker
Journal:  Br J Pharmacol       Date:  2002-12       Impact factor: 8.739

4.  Vault-related resistance to anticancer drugs determined by the expression of the major vault protein LRP.

Authors:  M A Izquierdo; G L Scheffer; A B Schroeijers; M C de Jong; R J Scheper
Journal:  Cytotechnology       Date:  1998-09       Impact factor: 2.058

5.  Broad distribution of the multidrug resistance-related vault lung resistance protein in normal human tissues and tumors.

Authors:  M A Izquierdo; G L Scheffer; M J Flens; G Giaccone; H J Broxterman; C J Meijer; P van der Valk; R J Scheper
Journal:  Am J Pathol       Date:  1996-03       Impact factor: 4.307

6.  Effect of GF120918, a potent P-glycoprotein inhibitor, on morphine pharmacokinetics and pharmacodynamics in the rat.

Authors:  S P Letrent; G M Pollack; K R Brouwer; K L Brouwer
Journal:  Pharm Res       Date:  1998-04       Impact factor: 4.200

Review 7.  Diagnostics of multidrug resistance in cancer.

Authors:  G Szakács; K Jakab; F Antal; B Sarkadi
Journal:  Pathol Oncol Res       Date:  1998       Impact factor: 3.201

8.  Tissue distribution of the multidrug resistance protein.

Authors:  M J Flens; G J Zaman; P van der Valk; M A Izquierdo; A B Schroeijers; G L Scheffer; P van der Groep; M de Haas; C J Meijer; R J Scheper
Journal:  Am J Pathol       Date:  1996-04       Impact factor: 4.307

9.  Lung resistance-related protein (LRP) expression in malignant ascitic cells as a prognostic marker for advanced ovarian serous carcinoma.

Authors:  Elizabeth H Kerr; Peter J Frederick; Michael E Egger; Cecil R Stockard; Jeffery Sellers; Debbie DellaManna; Denise K Oelschlager; Hope M Amm; Isam-Eldin Eltoum; J Michael Straughn; Donald J Buchsbaum; William E Grizzle; Lacey R McNally
Journal:  Ann Surg Oncol       Date:  2013-03-24       Impact factor: 5.344

10.  Development and characterization of a recombinant Madin-Darby canine kidney cell line that expresses rat multidrug resistance-associated protein 1 (rMRP1).

Authors:  Ziping Yang; Micha Horn; Joanne Wang; Danny D Shen; Rodney J Y Ho
Journal:  AAPS PharmSci       Date:  2004-03-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.